{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:09:31Z","timestamp":1779109771832,"version":"3.51.4"},"reference-count":67,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":137,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Advances in Hematology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Thrombotic risk refers to the likelihood of a thrombus, or blood clot, forming in the vascular system, which can obstruct blood flow and cause serious complications. This risk is closely linked to the function of physiological coagulation inhibitors. The causes of thrombosis are multiple, including damage to the vascular wall caused by blood vessel injury, trauma, surgery, or vascular inflammation; these can initiate stasis, or slow blood flow, thus promoting blood cell aggregation and clot formation. These factors are encountered during several pathological processes, including sickle cell disease. This study aimed to evaluate physiological coagulation inhibitors and their association with inflammation and to deduce the thrombotic risk in patients with sickle cell disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      We conducted an analytical cross\u2010sectional study over 1\u2009year. The Bafoussam Regional Hospital served as the framework for this research. The study population consisted of homozygous sickle cell patients regularly followed in the hospital and recruited in the hematology department. The collected blood samples were sent to the Hematology and Hemostasis laboratory. The analyses carried out were the hemogram by the flow cytometry method; the determination of the activity of protein C, protein S, and antithrombin with a coagulometer by the magnetic method; and finally, the exploration of inflammation from CRP dosage by the ultrasensitive method and the dosage of interleukin\u20106 by the ELISA sandwich method. The data obtained were recorded in an Excel 2013 spreadsheet and analyzed using the statistical software\n                      <jats:italic>R<\/jats:italic>\n                      Version 4.1.1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 150 homozygous sickle cell patients were included in this study. Of these, 98 (65.34%) presented a thrombotic risk. A high frequency of anemia (94.7%) was reported. Moreover, 82.7% and 64.0%, respectively, of leukocytosis and thrombocytosis were reported. An elevation of inflammatory parameters was observed characterized by an elevation of CRP (100% of patients at risk versus none in the group without it) and a significantly higher median IL\u20106 level in the group of patients at thrombotic risk (50.1 [28.7\u201376.6] [pg\/mL]) compared to those without it (32.3 [14.1\u201344.4] pg\/mL) (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). A decrease in coagulation inhibitors was observed, notably a significant decrease in protein C in patients with thrombotic risk compared to those without, with respective proportions of 71.6% and 50% (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). The median antithrombin level was 79.0% (77.0\u201392.0) in patients with thrombotic risk and 94.0% (84.0\u2013102) in those without (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Patients at risk of thrombosis had a significant decrease in protein S (76.6% vs. 50% [\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001]); the decrease in the latter was identified as a predictive factor of thrombotic risk during sickle cell disease (aOR\u2009=\u20091.5 [1.1; 5.2];\n                      <jats:italic>p<\/jats:italic>\n                      = 0.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reports a significant frequency of thrombotic risk in the sickle cell population characterized by a decrease in physiological coagulation inhibitors. This highlights the need for a systematic exploration of these markers for the prevention of cardiovascular disease in this patient group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/ah\/1400762","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:26:15Z","timestamp":1779107175000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross\u2010Sectional Study"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2867-0538","authenticated-orcid":false,"given":"Romaric De Manfouo","family":"Tuono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-8167","authenticated-orcid":false,"given":"Josu\u00e9 Louokdom","family":"Simo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paule Rita Ngamgwe","family":"Tchouanmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid Worti Sulem","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryline Seuko","family":"Njopwouo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-3105","authenticated-orcid":false,"given":"Claude Tagny","family":"Tayou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"e_1_2_12_1_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13641"},{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.02.008"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/mbc.0b013e32835187f8"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2005.11.010"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.07.011"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2001.115450"},{"key":"e_1_2_12_7_2","doi-asserted-by":"crossref","unstructured":"KhalidA. GhumlasA. GalilA. AbdelM. ZaidF. andFalehA. Natural Anticoagulants and Fibrinolytic Activity Following Interferon Therapy in Chronic Viral Hepatitis Blood Coagul Fibrinolysis 1 263\u2013267.","DOI":"10.1097\/MBC.0b013e3282f9b17f"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k06-176"},{"key":"e_1_2_12_9_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular Mechanisms of Fibrinolysis","volume":"129","author":"Cesarman-maus G.","year":"2005","journal-title":"British Journal of Haematology"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620959724"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2010.00582.x"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2392028"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/mbc.0b013e32833dbe68"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08074.x"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X"},{"key":"e_1_2_12_16_2","first-page":"1","article-title":"Vasculopathie Et Inflammation Dans La Dr\u00e9panocytose: I \u00c9tude Des D\u00e9terminants De La Vasculopathie Chronique En Afrique Sub-saharienne: Ii Dynamique Inflammatoire Des Polynucl\u00e9aires Neutrophiles Sous Th\u00e9rapeutiques Transfusionnelles Au Sein D\u2019Une Coh","author":"Abdoul Karim D.","year":"2021","journal-title":"Hyper Articles En Ligne Open Science"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2015.12.003"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000694"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.91"},{"key":"e_1_2_12_20_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00282-996-0279-2","article-title":"Abnormalities of Coagulation and Fibrinolysis in Homozygous Sickle Cell Disease","volume":"38","author":"Nsiri B.","year":"1996","journal-title":"Hematol Cell Ther"},{"key":"e_1_2_12_21_2","first-page":"173","article-title":"Hemostasis alterations in Sickle Cell Syndrome","volume":"55","author":"Higuera D.","year":"2014","journal-title":"Investigaci\u00f3n Cl\u00ednica"},{"key":"e_1_2_12_22_2","first-page":"1","article-title":"The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon","author":"Louokdom J. S.","year":"2025","journal-title":"An Analytical Cross-Sectional Study"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.28414"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20052"},{"key":"e_1_2_12_25_2","first-page":"17","article-title":"Thrombotic Events in Patients With Sickle Cell Anemia: Relationship to Protein C, S and Total Homocysteine Levels","volume":"2","author":"Al-maktari L. A. S.","year":"2014","journal-title":"Sickle Cell Disease"},{"key":"e_1_2_12_26_2","article-title":"Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols","volume":"1","author":"World Medical Association","year":"2013","journal-title":"Bull World Health Organ"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-016-0701-z"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029611420992"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/03630269.2018.1451340"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.02.026"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1179\/2046905511y.0000000009"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13416"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.3233\/ch-189013"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/mic.11.2.129.151"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-007-0177-7"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2007.08.014"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12744"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/03630269.2019.1651734"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.12.012"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2302"},{"key":"e_1_2_12_41_2","first-page":"1","article-title":"Homozygote Drepanocytosis: Ferric Status and Inflammation in World and Africa: Review Article and Meta Analysis","volume":"6","author":"Manfouo R. T. De","year":"2023","journal-title":"Health Science Reports"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.05.004"},{"key":"e_1_2_12_43_2","first-page":"237","article-title":"Africa: Beyond the Preliminary Data From Cameroon","volume":"18","author":"Wonkam A.","year":"2016","journal-title":"Perspectives in Genetics and Sickle Cell Disease Prevention in Africa"},{"key":"e_1_2_12_44_2","first-page":"263","article-title":"HHS Public Access","volume":"68","author":"Conran N.","year":"2019","journal-title":"Hematology"},{"key":"e_1_2_12_45_2","article-title":"Inflammation and Iron Profile in Children With Sickle Cell Disease in Cameroon: Frequency and Associated Factors, an Analytical Cross","volume":"45","author":"Tuono R. D. M.","year":"2025","journal-title":"Sectional Study"},{"key":"e_1_2_12_46_2","first-page":"405","article-title":"Steady State Hemoglobin Concentration and Packed Cell Volume in Homozygous Sickle Cell Disease Patients in Lagos, Nigeria","volume":"3","author":"Akinbami A.","year":"2012","journal-title":"Casp J Intern Med"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.45.10.902"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11011"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2012.e8"},{"key":"e_1_2_12_50_2","doi-asserted-by":"publisher","DOI":"10.1203\/pdr.0b013e31802d7754"},{"key":"e_1_2_12_51_2","article-title":"Association of Coagulation Activation With Clinical Complications in Sickle Cell Disease","volume":"7","author":"Ataga K. I.","year":"2012","journal-title":"Public Library of Science"},{"key":"e_1_2_12_52_2","article-title":"Platelet Count and Its Relationship to Haematocrit in Sickle Cell Anaemia Patients in Steady State","volume":"5","author":"Ahmed S. G.","year":"2015","journal-title":"Hematology"},{"key":"e_1_2_12_53_2","first-page":"30","article-title":"Haematological Profile and Blood Transfusion Pattern of Patients With Sickle Cell Anaemia Vary With Spleen Size","volume":"17","author":"Fasola F. A.","year":"2019","journal-title":"Annals of Ibadan Postgraduate Medicine"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.10.009"},{"key":"e_1_2_12_55_2","first-page":"303","article-title":"Opportunities to Improve Outcomes in Sickle Cell Disease","volume":"74","author":"Mehta S. R.","year":"2006","journal-title":"American Family Physician"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.9734\/bjmmr\/2016\/21539"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2000.11746536"},{"key":"e_1_2_12_58_2","doi-asserted-by":"crossref","unstructured":"WunT.andBrunsonA. Sickle Cell Disease: An Inherited Thrombophilia Hematology 5 640\u2013647.","DOI":"10.1182\/asheducation-2016.1.640"},{"key":"e_1_2_12_59_2","first-page":"592","article-title":"Natural Coagulation Inhibitors (Protein C, Protein S, Antithrombin) in Patients With Sickle Cell Anemia in a Steady State","volume":"1","author":"Article O.","year":"2001","journal-title":"Hematology, The ASH Education Program"},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2010.08.004"},{"key":"e_1_2_12_61_2","first-page":"1669","article-title":"Protein C and Free Protein S in Children with Sickle Cell Anemia","volume":"1","author":"Piccin A.","year":"2012","journal-title":"Hematology, The ASH Education Program"},{"key":"e_1_2_12_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.11.011"},{"key":"e_1_2_12_63_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia","volume":"1","author":"Morris C. R.","year":"2008","journal-title":"Hematology, The ASH Education Program"},{"key":"e_1_2_12_64_2","first-page":"20","article-title":"Orbital Mesenchymal Chondrosarcoma: Report of a Rare Tumor in a Nigerian Girl","volume":"11","author":"Ibrahim K. O. O.","year":"2020","journal-title":"Annals of Tropical Pathology"},{"key":"e_1_2_12_65_2","first-page":"1307","volume-title":"Journal of Thrombosis and Haemostasis","author":"Sparkenbaugh E.","year":"2017"},{"key":"e_1_2_12_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/moh.0b013e328363442f"},{"key":"e_1_2_12_67_2","first-page":"800","article-title":"Oxidative Stress, Inflammation, Blood Rheology, and Microcirculation in Adults With Sickle Cell Disease","author":"Connes P.","year":"2021","journal-title":"Effects of Hydroxyurea Treatment and Impact of Sickle Cell Syndrome"}],"container-title":["Advances in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/ah\/1400762","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/ah\/1400762","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/ah\/1400762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:26:22Z","timestamp":1779107182000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/ah\/1400762"}},"subtitle":[],"editor":[{"given":"Vittorio Emanuele","family":"Muccio","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/ah\/1400762"],"URL":"https:\/\/doi.org\/10.1155\/ah\/1400762","archive":["Portico"],"relation":{},"ISSN":["1687-9104","1687-9112"],"issn-type":[{"value":"1687-9104","type":"print"},{"value":"1687-9112","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1400762"}}